Navigation Links
Covance spars with animal rights activists

Madison, Wis. - The building of a state-of-the-art medical research facility that could help pharmaceutical and biotech companies test the safety of new drug candidates is being challenged by a vocal contingent of animal rights activists.

Slated for construction in Chandler, Ariz., the proposed facility represents the next significant capital investment for drug development giant <......

Full article >>> r first choice. This is where we want to be."

The move has provoked a renewed flurry of protest campaigns led by People for the Ethical Treatment of Animals (PETA), with direct support from the Physicians Committee for Responsible Medicine and Th......

Full article >>> exposures" by Covance have made several attempts to persuade citizens to withdraw their support.

PETA's web-based campaign, CovanceCruelty.com, depicts images of caged and screaming Macaques. The site's visceral centerpiece hinges on compiled video footage obtained between April 26, 2004 and March 11, 2005 by ......

Full article >>> of 80 percent still support the facility."

Alternatives to animal testing?

Testing drugs on animals in preclinical trials is a federally mandated procedure but critics claim that it is also an outdated one.

Alka Chandna, senior researcher at PETA, cited a March 2004 FDA report titled Challenge and Opportunity on the Critical Path to New Medical Products, which sta......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/22/06


Related biology technology :

1. Covance Appoints Co-Presidents for Early Development Services
2. Bifidobacterium animalis
3. Bifidobacterium animalis
4. High sensitivity quantitation of metabolites of nitrofuran antibiotics in animal tissue using LC/MS/MS
5. Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals
6. Human stem cells grown free of animal contamination
7. WARF is likely to hold on to stem cell patent rights
8. "Youre fired!" Trump wants trademark rights
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... it seems everyone has a chance to express their personalities. ... and dynamic community unlike any other. The businesses that succeed ... With their newest salon in Dunwoody ... that tradition with a unique, fresh approach to head lice ... newest of 13 nationwide locations, each of them well-situated in ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):